Mesenchymal stem cell insights: prospects in hematological transplantation

doi:10.3727/096368912X655172

中山醫學大學機構典藏 CSMUIR > 醫學科技學院 > 醫學檢驗暨生物技術學系暨碩士班 > 期刊論文 > Item 310902500/17911

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/17911

题名:	Mesenchymal stem cell insights: prospects in hematological transplantation
作者:	SH, Chou SZ, Lin CH, Day WW, Kuo CY, Shen DJ, Hsieh JY, Lin FJ, Tsai CH, Tsai CY, Huang
贡献者:	中山醫大
日期:	2013
上传时间:	2017-07-04T08:37:08Z (UTC)
出版者:	Cell Transplant
ISSN:	0963-6897
摘要:	Abstract Adult stem cells have been proven to possess tremendous potential in the treatment of hematological disorders, possibly in transplantation. Mesenchymal stem cells (MSCs) are a heterogeneous group of cells in culture, with hypoimmunogenic character to avoid alloreactive T-cell recognition as well as inhibition of T-cell proliferation. Numerous experimental findings have shown that MSCs also possess the ability to promote engraftment of donor cells and to accelerate the speed of hematological recovery. Despite that the exact mechanism remains unclear, the therapeutic ability of MSCs on hematologic transplantation have been tested in preclinical trials. Based on encouraging preliminary findings, MSCs might become a potentially efficacious tool in the therapeutic options available to treat and cure hematological malignancies and nonmalignant disorders. The molecular mechanisms behind the real efficacy of MSCs on promoting engraftment and accelerating hematological recovery are awaiting clarification. It is hypothesized that direct cell-to-cell contact, paracrine factors, extracellular matrix scaffold, BM homing capability, and endogenous metabolites of immunologic and nonimmunologic elements are involved in the interactions between MSCs and HSCs. This review focuses on recent experimental and clinical findings related to MSCs, highlighting their roles in promoting engraftment, hematopoietic recovery, and GvHD/graft rejection prevention after HSCT, discussing the potential clinical applications of MSC-based treatment strategies in the context of hematological transplantation.
URI:	http://dx.doi.org/10.3727/096368912X655172 https://ir.csmu.edu.tw:8080/ir/handle/310902500/17911
關聯:	Cell Transplant. 2013;22(4):711-21.
显示于类别:	[醫學檢驗暨生物技術學系暨碩士班] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	304	检视/开启

检视Licence

在CSMUIR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....